Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy.
Marco-Benedí V, Laclaustra M, Casado-Dominguez JM, Villa-Pobo R, Mateo-Gallego R, Sánchez-Hernández RM, Blanco Nuez M, Ortega-Martínez de Victoria E, Sitges M, Pedro-Botet J, Puzo J, Villarroel T, Civeira F. Marco-Benedí V, et al. J Clin Med. 2019 Dec 14;8(12):2209. doi: 10.3390/jcm8122209. J Clin Med. 2019. PMID: 31847331 Free PMC article.
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F; Dyslipemia Registry of Spanish Arteriosclerosis Society. Perez-Calahorra S, et al. Atherosclerosis. 2019 May;284:245-252. doi: 10.1016/j.atherosclerosis.2019.02.003. Epub 2019 Feb 12. Atherosclerosis. 2019. PMID: 30827715 Free article.
Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
Pérez-Calahorra S, Sánchez-Hernández RM, Plana N, Marco-Benedi V, Pedro-Botet J, Almagro F, Brea A, Ascaso JF, Lahoz C, Civeira F; Dyslipidemia Registry of Spanish Arteriosclerosis Society. Pérez-Calahorra S, et al. Am J Cardiol. 2017 Mar 1;119(5):742-748. doi: 10.1016/j.amjcard.2016.11.025. Epub 2016 Dec 2. Am J Cardiol. 2017. PMID: 28081939
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
Climent E, Marco-Benedí V, Benaiges D, Pintó X, Suárez-Tembra M, Plana N, Lafuente H, Ortega-Martínez de Victoria E, Brea-Hernando Á, Vila À, Civeira F, Pedro-Botet J. Climent E, et al. Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1594-1603. doi: 10.1016/j.numecd.2021.01.014. Epub 2021 Jan 28. Nutr Metab Cardiovasc Dis. 2021. PMID: 33744038
How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?
Masana L, Plana N, Pérez-Calahorra S, Ibarretxe D, Lamiquiz-Moneo I, Pedro-Botet J, Suárez-Tembra M, Valdivielso P, Ortega E, Civeira F; Dyslipidemia Registry of the Spanish Arteriosclerosis Society. Masana L, et al. Atherosclerosis. 2017 Jul;262:107-112. doi: 10.1016/j.atherosclerosis.2017.05.013. Epub 2017 May 12. Atherosclerosis. 2017. PMID: 28531826
Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
Masana L, Ibarretxe D, Rodríguez-Borjabad C, Plana N, Valdivielso P, Pedro-Botet J, Civeira F, López-Miranda J, Guijarro C, Mostaza J, Pintó X; Expert group from the Spanish Arteriosclerosis Society. Masana L, et al. Atherosclerosis. 2019 Aug;287:89-92. doi: 10.1016/j.atherosclerosis.2019.06.905. Epub 2019 Jun 20. Atherosclerosis. 2019. PMID: 31238171 Free article. Review.
357 results